SCHEMBL6026258

SCHEMBL6026258

COC(=O)c1sc2cc(F)c(OC)cc2c1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STING1 Q86WV6 1/20 0.51
MAPT P10636 5/20 0.45
GAA P10253 4/20 0.45
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 4/20 0.45
LMNA P02545 3/20 0.45
MAPK1 P28482 2/20 0.45
HTT P42858 2/20 0.45
PRNP P04156 1/20 0.45
TSHR P16473 1/20 0.45
PPARG P37231 1/20 0.45
MAPK10 P53779 1/20 0.45
NCOA2 Q15596 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
COMT P21964 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
BCKDK O14874 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
GLA P06280 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1609028 0.88 STING1 (0.63) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL6025665 0.87 BCKDK (0.56) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL6025520 0.87 STING1 (0.52) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL6026223 0.87 STING1 (0.47) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL6025631 0.86 L3MBTL1 (0.43) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL5226644 0.84 STING1 (0.52) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL6840237 0.81 COMT (0.45) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL1609893 0.81 STING1 (0.52) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL5745806 0.81 STING1 (0.52) STING1MAPTGAAALDH1A1KDM4E
SCHEMBL5226267 0.80 STING1 (0.51) STING1MAPTGAAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664037-A1 HALO SUBSTITUTED BENZO [B] THIOPHENES WITH PI3K INHIBITORY ACTIVITY AS THERAPEUTIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2006-06-07 EP disclosed
US-20050096350-A1 Halo substituted benzo[b]thiophenes as therapeutic agents CONNOLLY MICHAEL K (US) 2005-05-05 US disclosed
WO-2005023800-A1 HALO SUBSTITUTED BENZO`B! THIOPHENES WITH PI3K INHIBITORY ACTIVITY AS THERAPEUTIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096350-A1 Halo substituted benzo[b]thiophenes as therapeutic agents HCLS1, BRI3BP, BRPF1 STING1 2297/4885MAPT 4277/4885GAA 2724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.